Table 4.

Cross-stratification of cGvHD patients into respective risk groups by NIH consensus and IR score.

	Training cohort			Validation cohort			Total
	IR low risk	IR int risk	IR high risk	IR low risk	IR int risk	IR high risk
NIH consensus mild	12	10	3	0	1	1	27
NIH consensus moderate	7	17	6	5	3	6	44
NIH consensus severe	5	14	13	5	4	15	56
Total	24	41	22	10	8	22	127

IR, immune reconstitution score; int, intermediate.